Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosisIngo Tamm, Stephan Richter, Frank Scholz, et al.Haematologica|June 13, 2003
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrowWolfgang Kern, Susanne Danhauser-Riedl, Richard Ratei, et al.Cytometry. Part B, Clinical Cytometry|September 2, 2003
Correlation of protein expression and gene expression in acute leukemiaWolfgang Kern, Alexander Kohlmann, Christian Wuchter, et al.Genes, Chromosomes & Cancer|December 2, 2005
D324N single-nucleotide polymorphism in the FLT3 gene is associated with higher risk of myeloid leukemiasSusanne Schnittger, Tobias M Kohl, Nina Leopold, et al.Blood|October 24, 2002
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemiaRajani K Vangala, Marion S Heiss-Neumann, Janki S Rangatia, et al.Genes, Chromosomes & Cancer|February 24, 2004
Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patientsAndrea Zatkova, Reinhard Ullmann, Jean Marie Rouillard, et al.Cancer|March 5, 2005
Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-upTanja Lahaye, Birte Riehm, Ute Berger, et al.Oncogene|January 28, 2005
Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotypeKai Neben, Susanne Schnittger, Benedikt Brors, et al.Blood|June 19, 2002
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseSusanne Schnittger, Claudia Schoch, Martin Dugas, et al.Blood|August 27, 2005
CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL)Beate Gleissner, Nicola Goekbuget, Harald Rieder, et al.Pageof 9